{
    "Orphapacket": {
        "ORPHApacketId": "319462",
        "creationDate": "2021-08-17 17:32:38",
        "version": "1.3.7 / 4.1.7 [2020-12-03] (orientdb version)",
        "copyright": "Orphanet (c) 2021",
        "ORPHAcode": "319462",
        "Label": "Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_319462",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "605724",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations is a rare cancer-predisposing syndrome associated with the D1 subgroup of Fanconi anemia (FA) characterized by progressive bone marrow failure cardiac brain intestinal or skeletal abnormalities and predisposition to various malignancies. Bone marrow suppression and the incidence of developmental abnormalities are less frequent than in other FA but cancer risk is very high with the spectrum of childhood cancers including Wilms tumor brain tumor (often medulloblastoma) and ALL/AML."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "BRCA2",
                    "Name": "BRCA2 DNA repair associated",
                    "ExternalReferences": []
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "319328",
                        "Label": "Inherited renal cancer-predisposing syndrome"
                    }
                ]
            }
        ]
    }
}